NASDAQ: CLDXCelldex Therapeutics Inc Earnings Dates, Reports, Calls
Celldex Therapeutics earnings were -$178.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CLDX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$53.8M, up 14.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLDX reported annual earnings of -$157.9M, with 11.6% growth.
CLDX earnings history
Current Revenue
$7.6M
Current Earnings
-$178.9M
Current Profit Margin
-2,366.1%
CLDX Return on Equity
Current Company
-23.5%
Current Industry
-60.5%
Current Market
28.3%
CLDX's Return on Equity (-23.5%)... subscribe to Premium to read more.
High Return on Equity Performance
CLDX undefined
Current Company
-22.4%
Current Industry
-2.3%
CLDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when CLDX announces earnings.
CLDX undefined
Current Company
-25.28%
Current Industry
6.2%
CLDX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
CLDX vs Biotech Stocks
Celldex Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.